首页|期刊导航|新中医|化饮止鼽汤治疗中重度变应性鼻炎临床研究

化饮止鼽汤治疗中重度变应性鼻炎临床研究OA

Clinical Study on Huayin Zhiqiu Decoction for Moderate to Severe Allergic Rhinitis

中文摘要英文摘要

目的:观察化饮止鼽汤治疗中重度变应性鼻炎(AR)的临床疗效.方法:选取2024年1-12月余姚市中医医院收治的60例中重度AR患者,按随机数字表法分为对照组和联合组各30例.对照组给予常规西药治疗,联合组在对照组的基础上加用化饮止鼽汤治疗.比较2组临床疗效、中医证候评分、鼻部症状评分(TNSS)、白细胞介素-18(IL-18)、白细胞介素-1β(IL-1β)、黏蛋白-5AC(MUC5AC)水平与不良反应.结果:治疗后,联合组总有效率为96.67%(29/30),对照组为70.00%(21/30),2组比较,差异有统计学意义(P<0.05).治疗后,2组主、次症证候评分均较治疗前降低(P<0.05),且联合组主、次症证候评分均低于对照组(P<0.05).治疗后,2组TNSS量表中鼻塞、鼻痒、喷嚏、流涕评分均较治疗前降低(P<0.05),且联合组4项症状评分均低于对照组(P<0.05).治疗后,2组血清IL-18、IL-1β、MUC5AC水平均较治疗前降低(P<0.05),且联合组IL-18、IL-1β、MUC5AC水平均低于对照组(P<0.05).治疗期间,2组患者均未出现皮肤过敏反应、肝肾功能损害等不良反应.结论:化饮止鼽汤联合常规西药治疗中重度AR疗效肯定,能够明显缓解鼻部症状,改善中医证候,减轻鼻黏膜炎症反应,提高患者生活质量.

Objective:To observe the clinical efficacy of Huayin Zhiqiu Decoction in treating moderate to severe allergic rhinitis(AR).Methods:A total of 60 patients with moderate to severe AR admitted to Yuyao Hospital of Traditional Chinese Medicine from January to December 2024 were selected and randomly divided into a control group and a combination group according to a random number table method,with 30 cases in each group.The control group received conventional western medication,while the combination group received additional Huayin Zhiqiu Decoction based on the control group's treatment.Clinical efficacy,traditional Chinese medicine syndrome scores,Total Nasal Symptom Score(TNSS),interleukin-18(IL-18),interleukin-1β(IL-1β),mucin-5AC(MUC5AC)levels,and adverse reactions were compared between the two groups.Results:After treatment,the total effective rate was 96.67%(29/30)in the combination group and 70.00%(21/30)in the control group,with the difference being significant(P<0.05).The scores for primary and secondary symptoms of traditional Chinese medicine syndrome decreased in both groups compared to before treatment(P<0.05),and the combination group had lower scores than the control group(P<0.05).The scores for nasal congestion,nasal itching,sneezing,and rhinorrhea in the TNSS decreased in both groups compared to before treatment(P<0.05),and the combination group had lower scores for all four symptoms than the control group(P<0.05).Serum levels of IL-18,IL-1β,and MUC5AC decreased in both groups compared to before treatment(P<0.05),and the combination group had lower levels of these markers than the control group(P<0.05).During treatment,no adverse reactions such as skin allergies or liver/kidney function impairment were observed in either group.Conclusion:Huayin Zhiqiu Decoction combined with conventional western medication demonstrates definite efficacy in treating moderate to severe AR.It significantly alleviates nasal symptoms,improves traditional Chinese medicine syndromes,reduces nasal mucosal inflammatory responses,and enhances patients'quality of life.

张佳颖;赵王镮;孙佳宁;朱铭

余姚市中医医院内科,浙江 余姚 315400余姚市中医医院内科,浙江 余姚 315400余姚市人民医院耳鼻咽喉科,浙江 余姚 315400余姚市中医医院内科,浙江 余姚 315400

医药卫生

变应性鼻炎化饮止鼽汤鼻部症状评分白细胞介素-18白细胞介素-1β黏蛋白-5AC

Allergic rhinitisHuayin Zhiqiu DecoctionTotal Nasal Symptom ScoreInterleukin-18Interleukin-1βMucin-5AC

《新中医》 2026 (10)

42-47,6

浙江省中医药科技计划项目(2024ZR163)

10.13457/j.cnki.jncm.2026.10.007

评论